Michal Novák
About
Michal Novák is a scholar working on Physiology, Molecular Biology and Cellular and Molecular Neuroscience.
According to data from OpenAlex, Michal Novák has authored 116 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Physiology, 52 papers in Molecular Biology and 37 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michal Novák's work include Alzheimer's disease research and treatments (84 papers), Neuroscience and Neuropharmacology Research (27 papers) and Neuroinflammation and Neurodegeneration Mechanisms (22 papers). Michal Novák is often cited by papers focused on Alzheimer's disease research and treatments (84 papers), Neuroscience and Neuropharmacology Research (27 papers) and Neuroinflammation and Neurodegeneration Mechanisms (22 papers). Michal Novák collaborates with scholars based in Slovakia, United States and Italy. Michal Novák's co-authors include Norbert Žilka, Inge Grundke‐Iqbal, Khalid Iqbal, Alejandra del C. Alonso, Tanweer Zaidi, Eva Kontseková, Branislav Kováčech, Rostislav Škrabana, Petr Novák and Peter Filipčík and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
In The Last Decade
Michal Novák
115 papers receiving 5.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Michal Novák Slovakia | 38 | 3.7k | 2.2k | 1.4k | 1.2k | 839 | 116 | 5.3k | ||
| Philippe Marambaud United States | 38 | 2.8k 0.8× | 3.1k 1.4× | 1.2k 0.8× | 649 0.5× | 899 1.1× | 87 | 6.6k | ||
| Kimberly Scearce‐Levie United States | 35 | 3.0k 0.8× | 2.4k 1.1× | 2.1k 1.5× | 896 0.7× | 974 1.2× | 55 | 5.8k | ||
| Andréa C. LeBlanc Canada | 44 | 2.6k 0.7× | 4.5k 2.0× | 1.3k 0.9× | 1.4k 1.1× | 635 0.8× | 103 | 6.9k | ||
| Jorge Busciglio United States | 43 | 4.3k 1.2× | 3.5k 1.6× | 1.7k 1.2× | 1.1k 0.9× | 996 1.2× | 65 | 7.9k | ||
| Wayne W. Poon United States | 34 | 2.5k 0.7× | 2.2k 1.0× | 1.3k 0.9× | 1.1k 0.9× | 546 0.7× | 52 | 4.7k | ||
| Carmela R. Abraham United States | 48 | 4.1k 1.1× | 3.7k 1.7× | 1.4k 1.0× | 1.7k 1.4× | 709 0.8× | 126 | 9.1k | ||
| Christopher Janus United States | 30 | 4.3k 1.2× | 2.4k 1.1× | 2.4k 1.7× | 1.8k 1.4× | 1.1k 1.3× | 53 | 6.9k | ||
| Efrat Levy United States | 45 | 3.9k 1.1× | 3.8k 1.7× | 872 0.6× | 1.1k 0.9× | 563 0.7× | 105 | 7.5k | ||
| Joseph F. Poduslo United States | 51 | 2.9k 0.8× | 2.6k 1.2× | 1.7k 1.2× | 794 0.6× | 427 0.5× | 123 | 6.7k | ||
| Melanie Meyer‐Luehmann Germany | 30 | 3.5k 1.0× | 2.0k 0.9× | 1.5k 1.1× | 2.2k 1.7× | 646 0.8× | 45 | 5.6k |
Countries citing papers authored by Michal Novák
Since
Specialization
Citations
This map shows the geographic impact of Michal Novák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Novák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Novák more than expected).
Fields of papers citing papers by Michal Novák
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Michal Novák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Novák. The network helps show where Michal Novák may publish in the future.
Co-authorship network of co-authors of Michal Novák
This figure shows the co-authorship network connecting the top 25 collaborators of Michal Novák. A scholar is included among the top collaborators of Michal Novák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michal Novák. Michal Novák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Katina, Stanislav, Jana Farbáková, Aladár Maďari, Michal Novák, & Norbert Žilka. (2015). Risk factors for canine cognitive dysfunction syndrome in Slovakia. Acta veterinaria Scandinavica. 58(1). 17–17.
2.
Mravec, Boris, Peter Vargovič, Peter Filipčík, Michal Novák, & Richard Květňanský. (2015). Effect of a single and repeated stress exposure on gene expression of catecholamine biosynthetic enzymes in brainstem catecholaminergic cell groups in rats. European Journal of Neuroscience. 42(2). 1872–1886.
3.
Kontseková, Eva, Norbert Žilka, Branislav Kováčech, Petr Novák, & Michal Novák. (2014). First-in-man tau vaccine targeting structural determinants essential for pathological tau–tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer’s disease model. Alzheimer s Research & Therapy. 6(4). 44–44.
4.
Javor, Juraj, et al.. (2010). No association between cytokine gene polymorphism and risk of Alzheimer´s disease in Slovaks. Acta Neurobiologiae Experimentalis. 70(3). 303–307.
5.
Kováčech, Branislav, Rostislav Škrabana, & Michal Novák. (2010). Transition of Tau Protein from Disordered to Misordered in Alzheimer’s Disease. Neurodegenerative Diseases. 7(1-3). 24–27.
6.
Škrabana, Rostislav, et al.. (2009). P3‐199: Intrinsically disordered protein tau with unsheltered microtubule‐binding domain become mis‐disordered: Implications for neurofibrillary degeneration. Alzheimer s & Dementia. 5(4S_Part_13).
7.
Bhide, Mangesh, Rastislav Mucha, Ivan Mikula, et al.. (2009). Novel mutations in TLR genes cause hyporesponsiveness to Mycobacterium avium subsp. paratuberculosis infection. BMC Genetics. 10(1). 21–21.
8.
Žilka, Norbert, et al.. (2009). Human misfolded truncated tau protein promotes activation of microglia and leukocyte infiltration in the transgenic rat model of tauopathy. Journal of Neuroimmunology. 209(1-2). 16–25.
9.
Žilka, Norbert, et al.. (2009). Misfolded tau protein and disease modifying pathways in transgenic rodent models of human tauopathies. Acta Neuropathologica. 118(1). 71–86.
10.
Koson, Peter, Norbert Žilka, Andrej Kováč, et al.. (2008). Truncated tau expression levels determine life span of a rat model of tauopathy without causing neuronal loss or correlating with terminal neurofibrillary tangle load. European Journal of Neuroscience. 28(2). 239–246.
11.
Žilka, Norbert, Eva Kontseková, & Michal Novák. (2008). Chaperone-like Antibodies Targeting Misfolded Tau Protein: New Vistas in the Immunotherapy of Neurodegenerative Foldopathies. Journal of Alzheimer s Disease. 15(2). 169–179.
12.
Kováčech, Branislav, Eva Kontseková, Norbert Žilka, et al.. (2007). A novel monoclonal antibody DC63 reveals that inhibitor 1 of protein phosphatase 2A is preferentially nuclearly localised in human brain. FEBS Letters. 581(4). 617–622.
13.
Šoltýs, Katarína, et al.. (2005). First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease. Neuroreport. 16(15). 1677–1681.
14.
Škrabana, Rostislav, et al.. (2004). Rapid purification of truncated tau proteins: model approach to purification of functionally active fragments of disordered proteins, implication for neurodegenerative diseases. Protein Expression and Purification. 35(2). 366–372.
15.
Alonso, Alejandra del C., Tanweer Zaidi, Michal Novák, et al.. (2001). Interaction of Tau Isoforms with Alzheimer's Disease Abnormally Hyperphosphorylated Tau and in VitroPhosphorylation into the Disease-like Protein. Journal of Biological Chemistry. 276(41). 37967–37973.
16.
Sengupta, Amitabha, Juraj Kabát, Michal Novák, et al.. (1998). Phosphorylation of Tau at Both Thr 231 and Ser 262 Is Required for Maximal Inhibition of Its Binding to Microtubules. Archives of Biochemistry and Biophysics. 357(2). 299–309.
17.
Kontseková, Eva, et al.. (1992). Conformation-Dependent Accessibility of the Linear Epitopes Located on the Rabies Virus Glycoprotein. Viral Immunology. 5(3). 213–220.
18.
Kontsek, P, et al.. (1991). Distinct Effect of pH 2 on a Common Antigenic Structure Found in Human Interferons-α 1 and -α 2 in the Region 30–35. Journal of Interferon Research. 11(6). 327–332.
19.
Mena, Raúl, Claude M. Wischik, Michal Novák, César Milstein, & A. Claudio Cuello. (1991). A Progressive Deposition of Paired Helical Filaments (PHF) in the Brain Characterizes the Evolution of Dementia in Alzheimerʼs Disease.. Journal of Neuropathology & Experimental Neurology. 50(4). 474–490.
20.
Kontsek, P, et al.. (1990). Antigenic Link Between Human Interferons-α and -β: The Common Epitope 1. Journal of Interferon Research. 10(2). 119–128.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Philippe Marambaud Breakdown of academic impact, for papers by Kimberly Scearce‐Levie Breakdown of academic impact, for papers by Andréa C. LeBlanc Breakdown of academic impact, for papers by Jorge Busciglio Breakdown of academic impact, for papers by Wayne W. Poon Breakdown of academic impact, for papers by Carmela R. Abraham Breakdown of academic impact, for papers by Christopher Janus Breakdown of academic impact, for papers by Efrat Levy Breakdown of academic impact, for papers by Joseph F. Poduslo Breakdown of academic impact, for papers by Melanie Meyer‐Luehmann